Početna › Limfom › Pennsylvania › Pittsburgh
Kliničke studije za Limfom u gradu Pittsburgh, PA
10 studija za Limfom traži sudionike na lokacijama u gradu Pittsburgh i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
U tijeku regrutacijaFaza 2
- UPMC Hillman Cancer Center, Pittsburgh
Collection of Tissue Samples for Cancer Research
U tijeku regrutacijaOpažajna studija
- University of Pittsburgh Medical Center, Pittsburgh
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
U tijeku regrutacijaFaza 1/2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
U tijeku regrutacijaFaza 3
- Research Site, Pittsburgh
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
U tijeku regrutacijaFaza 1/2
- West Penn Hospital, Pittsburgh
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
U tijeku regrutacijaFaza 3
- Allegheny Health Network, Pittsburgh
DALY II USA/ MB-CART2019.1 for DLBCL
U tijeku regrutacijaFaza 2
- Allegheny Health Network Cancer Institute, Pittsburgh
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
U tijeku regrutacijaFaza 1/2
- Dren Investigational Site 2, Pittsburgh
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
U tijeku regrutacijaFaza 1/2
- UPMC Hilman Cancer Center, Pittsburgh
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
U tijeku regrutacijaFaza 1
- University of Pittsburgh Medical Center (UPMC), Pittsburgh
Studije za Limfom u drugim gradovima
- Houston, TX34 studija
- Boston, MA33 studija
- New York City, NY33 studija
- Washington, DC23 studija
- Baldwin Park, CA21 studija
- Chicago, IL20 studija
- Durham, NC17 studija
- St. Louis, MO15 studija
- Philadelphia, PA15 studija
- Cleveland, OH14 studija
- Edison, NJ12 studija
- Atlanta, GA12 studija
Ostale studije u gradu Pittsburgh
- Nemikrocelularni karcinom pluća48 studija
- Rak (sve vrste)41 studija
- Rak dojke39 studija
- Kolorektalni rak32 studija
- Metastatski karcinom31 studija
- Melanom31 studija
- Rak jajnika30 studija
- Rak endometrija23 studija
- Rak pluća23 studija
- Rak prostate23 studija
- Moždani udar22 studija
- Pločastostanični karcinom glave i vrata22 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.